Congressman Chris Collins announced $224,975 in federal funding for Neurovascular Diagnostics Inc. located in Buffalo. This grant was awarded through the Department of Health and Human Services’ National Institute of Neurological Disorders and Stroke.
This award will be used to fund the Neurovascular Diagnostics’ molecular biomarkers of dangerous intracranial aneurysms project, which aims to develop a novel blood diagnostic to detect unruptured intracranial aneurysms in a patients who show no symptoms.
“This project funding is vital for the 2%-5% of Americans who have unruptured intracranial aneurysms and do not know it,” Collins said. “Researchers will now have the ability to develop screening technology to treat patients, which will reduce the rate of ruptures and deaths.”
Currently, there are no quality screening tools to identify patients with unruptured intracranial aneurysms. Moreover, 300,000 Americans suffer from intracranial aneurysm without knowledge each year, with 10%-15% dying on the way to the hospital, and 30%-40% dying within a month.